Vaccines@UQ Symposium

The Vaccines@UQ symposium will take place at The University of Queensland (UQ) on Monday 25 November and Tuesday 26 November 2019.

The symposium will feature presentations by national and international researchers showcasing the latest scientific discoveries in vaccine research. The program will also highlight research being undertaken across South East Queensland.

Attendance numbers are limited therefore we encourage you to register your attendance as soon as possible.

The full program and presentation abstracts are available to download here. 

Program

Time Presentation
2.20pm Welcome
Prof. Ian Henderson, Co-Chair of the Symposium 
Deputy Director (Research) - Institute of Molecular Biosciences, The University of Queensland
2.30pm Group A Streptococcus vaccines - animal models and adjuvants
Prof. Mark Walker, Australian Infectious Diseases Research Centre,
School of Chemistry and Molecular Biosciences, The University of Queensland
3.00pm Animal tick vaccines- realisTICK progress and challenges​
Prof. Ala Tabor, QAAFI, The University of Queensland
3.30pm Harnessing the Therapeutic Potential of Interleukin-22 in Neonatal Respiratory
Viral Infection

Dr Sumaira Hasnain, Group Leader - Mater Research Institute, The University of Queensland
4.00pm KEYNOTE PRESENTATION: Features of protective antibody responses to Salmonella
Prof. Adam Cunningham, University of Birmingham

Time Presentation
9.00am Welcome
Prof. Paul Young, Co-Chair of the Symposium 
Head of School of Chemistry and Molecular Biosciences, The University of Queensland
9.10am KEYNOTE PRESENTATION: Enhancing group A streptococcal vaccine design through global population genomics and nonhuman primate infection studies
Dr Mark Davies, Doherty Institute, University of Melbourne
10.00am The development of single-dose vaccine technologies for large animals​
Prof. Timothy Mahony, QAAFI, The University of Queensland
10.30am Defined Semisynthetic Platforms for Producing Potent Semisynthetic Protein-TLR2 Agonist Fusion Vaccines
Dr Peter Michael Moyle, Senior Lecturer - School of Pharmacy, The University of Queensland
11.30am Evaluation of a novel chimeric dengue vaccine candidate delivered to the skin by high-density microarray patches in an infectious challenge mouse model
Dr David Muller, School of Chemistry and Molecular Biosciences,
The University of Queensland
12.00pm Self-assembling and self-adjuvanting lipopeptide nanoparticulate vaccine candidates for the induction of protective immune responses
Prof. Istvan Toth, School of Chemistry and Molecular Biosciences,
The University of Queensland
12.30pm Vaccine development for gonococcal superbugs
A/Prof. Kate Seib, Research Leader & Associate Director (Research) - Institute for Glycomics, Griffith University
2.00pm Rapid response pipeline for stabilised subunit vaccines
Dr Keith Chappell, School of Chemistry and Molecular Biosciences,
The University of Queensland
2.30pm The Chlamydia epidemic: What do we need from a vaccine?
Prof. Kenneth Beagley, Biomedical Sciences, Queensland University of Technology
3.00pm Sementis Copenhagen Vector, a new vaccinia-based vaccine platform; application to ZIKA/CHIK vaccine development
Prof. Andreas Suhrbier, QIMR Berghofer Medical Research Institute
3.30pm Vaccine delivery to the skin: benefits and challenges
Dr Angus Forster, Chief Development and Operating Officer, Vaxxas Pty Ltd
4.30pm SKERMAN LECTURE: Novel technologies for discovery, design and development of new and effective vaccines
Prof. Mariagrazia Pizza, Senior Scientific Director, Bacterial Vaccines, GSK VACCINES

Location

Level 3 Auditorium
Queensland Biosciences Precinct (Building 80)
St Lucia - The University of Queensland

Participants

Contacts

SCMB Research Administration
+61 7 3443 2595